FDA Inspection 952658 — Galephar Pharmaceutical Research Inc.

Galephar Pharmaceutical Research Inc. — FEI 3003068480

The FDA completed an inspection of Galephar Pharmaceutical Research Inc. on Nov 23, 2015 in Juncos, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 23, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Juncos, PR (United States)

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.